Inhibitors of carbonic anhydrase IX

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8877970
SERIAL NO

12350894

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by over expression of CA-IX comprise a complex that contains a sulfonamide moiety which is capable of binding the active catalytic site of CA-IX, and a radionuclide adapted for radioimaging and/or radiotherapy:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MOLECULAR INSIGHT PHARMACEUTICALS INCONE WORLD TRADE CENTER 47TH FLOOR SUITE J NEW YORK NY 10007

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babich, John W Cambridge, US 88 1375
Barone, Chris Roxbury Crossing, US 3 88
Joyal, John Melrose, US 12 414
Lu, Genliang Winchester, US 48 841
Maresca, Kevin P Tewksbury, US 28 743
Zimmerman, Craig Topsfield, US 40 957

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 4, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00